TrueWealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$913K Buy
7,109
+525
+8% +$61.5K 0.21% 101
2026
Q1
$792K Buy
6,584
+4,433
+206% +$512K 0.2% 96
2025
Q4
$226K Buy
+2,151
New +$202K 0.06% 221
2025
Q1
Sell
-2,229
Closed -$222K 230
2024
Q4
$222K Buy
2,229
+83
+4% +$8.56K 0.07% 207
2024
Q3
$244K Sell
2,146
-22
-1% -$2.61K 0.08% 193
2024
Q2
$268K Sell
2,168
-42
-2% -$5.41K 0.1% 184
2024
Q1
$292K Buy
2,210
+188
+9% +$23.2K 0.11% 150
2023
Q4
$220K Buy
2,022
+38
+2% +$3.94K 0.09% 179
2023
Q3
$204K Buy
1,984
+174
+10% +$18.8K 0.09% 187
2023
Q2
$209K Sell
1,810
-212
-10% -$24.1K 0.09% 180
2023
Q1
$215K Buy
2,022
+26
+1% +$2.81K 0.09% 174
2022
Q4
$221K Buy
+1,996
New +$204K 0.1% 165

Other funds holding MRK

TrueWealth Advisors's MRK Position: Q2 2026 in Review

TrueWealth Advisors increased its Merck (MRK) stake by 8% in Q2 2026, buying an estimated $61.5K and bringing the position to 7,109 shares worth $913K. The position accounts for 0.21% of the portfolio, ranked #101.

TrueWealth Advisors first reported a position in MRK in Q4 2022 and has held it in 12 quarters since. 1,835 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • TrueWealth Advisors held 7,109 shares of Merck worth $913K as of Q2 2026.
  • TrueWealth Advisors bought 525 Merck shares in Q2 2026, an estimated $61.5K.
  • Merck made up 0.21% of TrueWealth Advisors's portfolio in Q2 2026, its #101 holding.
  • TrueWealth Advisors first reported a position in Merck in Q4 2022 and has held it in 12 quarters since.
  • 1,835 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on TrueWealth Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.